Bullboard - Stock Discussion Forum Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s): RQHTF

Healthcare Medical Devices

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and... see more

Add To Watchlist

TSXV:RHT.H - Post Discussion

Reliq Health Technologies Inc > Contract/4 MED. PRACTICES IN US/2000 PATIENTS IN EARLY 2022

View:

Post by Humanist on Oct 21, 2021 7:57am

Contract/4 MED. PRACTICES IN US/2000 PATIENTS IN EARLY 2022

Reliq Health Technologies, Inc. Announces New Contracts with Four US Physician Practices, Adding over 2,000 New Patients

by @nasdaq on 21 Oct 2021, 03:01

HAMILTON, Ontario, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it has signed contracts with four new primary care physician practices in the US to provide its iUGO Care platform to their chronic disease patients.
“We are excited to be adding these four new physician practices and their Medicare and Medicaid patients,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “As both Medicaid and Medicare expand the scope of their virtual care programs to include additional conditions such as high risk pregnancy, solid organ disease, musculoskeletal conditions and others, the eligible patient population for Reliq’s products and services continues to increase.

Demand for the iUGO Care platform is steadily increasing as clinicians recognize the significant revenue potential associated with offering virtual care programs to their at-risk patients.

As we predicted at the beginning of this year, we are experiencing tremendous growth in the second half of 2021 after a relatively quiet first half of the year due to the pandemic.

We expect to onboard over 2,000 patients with these clients at an average revenue of $50 USD per patient per month for Reliq. Onboarding will begin this month and is expected to be completed in early 2022.”

209